Overexpression of eNOS decrease tissue factor (TF) level in CD34+ cells exhibit increased antithrombogenic property in small caliber vascular graft

The Journal of Cardiovascular Surgery
Feng WangQingjun You

Abstract

Endothelial progenitor cells (EPCs) have reduced expression of eNOS, this may decrease their antithrombogenic property when used as seeding cells for small caliber vascular graft. The aim of this study is to investigate whether overexpression of eNOS in EPCs can increase its antithrombogenic property and regulate tissue factor (TF) level. CD34+ cells were isolated from canine bone marrow. Differentiation of CD34 cells into endothelial cells was inducted by VEGF. Overexpression of eNOS in CD34+ cells were obtained by transfection with eNOS plasmid. TF expression was examined by western blot after TNFα stimulation. Platelets adhesion assay was performed to determine antiplatelet adhesion property of the cells in vitro. The cells were seeded onto the lumimal surface of small caliber vascular graft and implanted in vivo. The thrombopoiesis in vivo were examined by SEM. Transfection with eNOS gene decreased the level of TF in CD34+ cells. The expression of TF increased after stimulation with TNFα in time dependent manner, this effect was abrogated by eNOS gene transfection. Overexpression of eNOS significantly inhibited the platelet adhesion on EPCs in vitro. Over expression of eNOS in CD34+ cells also decreased thrombopoiesis and f...Continue Reading

References

Jan 1, 1990·Annals of Vascular Surgery·H P Greisler
May 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·T MuroharaJ M Isner
Sep 13, 2002·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tarja A KunnasPekka J Karhunen
Feb 25, 2005·Annals of Surgery·Seung-Woo ChoByung-Soo Kim
Jul 9, 2005·Nature Biotechnology·Rakesh K JainDai Fukumura
Nov 2, 2006·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Sandip SarkarAlexander M Seifalian
Feb 28, 2007·Acta Clinica Belgica·F Desjardins, J L Balligand
Mar 30, 2007·Journal of Interventional Cardiology·Chunming Dong, Pascal J Goldschmidt-Clermont
Jul 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Craig K HashiSong Li
Nov 29, 2007·Journal of Biomedical Materials Research. Part a·Monica T HindsStephen R Hanson
Jan 21, 2010·Tissue Engineering. Part B, Reviews·Gustavo A VillalonaChristopher K Breuer
Mar 9, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jason D RohChristopher K Breuer
Mar 4, 2011·Journal of Biomedical Materials Research. Part a·Xing ZhangYogesh K Vohra
May 10, 2011·Trends in Biotechnology·Omar F Khan, Michael V Sefton
Oct 6, 2012·Acta Biomaterialia·Frédéric VelardPatrice Laquerriere
Dec 21, 2012·Tissue Engineering. Part B, Reviews·Anthony J MelchiorriJohn P Fisher
Apr 22, 2014·Journal of Vascular Surgery·Shuhei TaraToshiharu Shinoka

❮ Previous
Next ❯

Citations

Apr 11, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Arthur J A LeloupPaul Fransen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.